FDA 483 - Ionetix Corporation - September 14, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Ionetix Corporation in El Paso, TX, a PET drug manufacturer, was cited with two observations during an FDA inspection from September 11-14, 2023. The inspection revealed inadequate facility controls for contamination prevention, specifically lacking viable surface sampling in an ISO 5 hood, and deficiencies in laboratory testing procedures, including unvalidated incubation conditions for environmental and personnel monitoring media. These issues indicate potential risks to product quality and purity.
ID · 996d8b24-d64e-46ca-a6fd-e37dfadc708c